Feasibility of multimodal therapy for rhabdomyosarcoma in a patient with Fukuyama congenital muscular dystrophy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Feasibility of multimodal therapy for rhabdomyosarcoma in a patient with Fukuyama congenital muscular dystrophy

Published:2024-04-28 Issue:7 Volume:71 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Sugiyama Masanaka¹,Arakawa Ayumu¹²,Iwata Shintaro²³,Tao Kayoko¹,Shirakawa Nami¹^ORCID,Watanabe Yuko¹,Nakajima Miho¹,Yoshida Akihiko⁴,Ishigaki Keiko⁵,Kawai Akira²³,Ogawa Chitose¹²

Affiliation:

1. Department of Pediatric Oncology National Cancer Center Hospital Tokyo Japan

2. Rare Cancer Center National Cancer Center Hospital Tokyo Japan

3. Department of Musculoskeletal Oncology and Rehabilitation National Cancer Center Hospital Tokyo Japan

4. Department of Diagnostic Pathology National Cancer Center Hospital Tokyo Japan

5. Department of Pediatrics Tokyo Women's Medical University School of Medicine Tokyo Japan

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.31036

Reference8 articles.

1. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy

2. Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803

3. Duchenne Muscular Dystrophy and Concomitant Metastatic Alveolar Rhabdomyosarcoma

4. Rhabdomyosarcoma in a Patient With Duchenne Muscular Dystrophy: A Possible Association

5. A high‐risk alveolar rhabdomyosarcoma case with Duchenne muscular dystrophy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP